Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eyes With Retinal Disease”

1,839 trials

Showing 20 of 1,839 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Testing effectiveness (Phase 2)Active Not RecruitingNCT03326336
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Who this might be right for
Non-syndromic Retinitis Pigmentosa
GenSight Biologics 10
Large-scale testing (Phase 3)Study completedNCT00121407
What this trial is testing

Visudyne® in Occult (VIO)

Who this might be right for
Macular Degeneration
QLT Inc. 364
Not applicableStudy completedNCT04778436
What this trial is testing

Macula Evolution in Patients With AMD Taking Oral Food Supplementation

Who this might be right for
Age Related Macular Degeneration
Laboratoires Thea 10
Early research (Phase 1)Study completedNCT02792036
What this trial is testing

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 8
Post-approval studies (Phase 4)Study completedNCT00331435
What this trial is testing

PDT Study for Exudative AMD With PCV

Who this might be right for
Age Related Macular Degeneration
Ophthalmic PDT Study Group 113
Not applicableTemporarily pausedNCT04639635
What this trial is testing

CNGB1 and Allied Disorders

Who this might be right for
Retinitis Pigmentosa Associated With CNGB1 Mutations
Columbia University 20
Post-approval studies (Phase 4)Study completedNCT02689518
What this trial is testing

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Who this might be right for
Macular DegenerationWet Macular Degeneration
University of California, San Diego 50
Not applicableStudy completedNCT01946997
What this trial is testing

Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography

Who this might be right for
Diabetic Retinopathy
Johns Hopkins University 200
Early research (Phase 1)Study completedNCT02848313
What this trial is testing

An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stealth BioTherapeutics Inc. 40
Not applicableStudy completedNCT04883697
What this trial is testing

Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique

Who this might be right for
Macular Holes
Vienna Institute for Research in Ocular Surgery 71
Not applicableStudy completedNCT01792154
What this trial is testing

Measuring Corneal Cells With Specular Microscopy

Who this might be right for
Retinal Diseases
Retina Institute of Hawaii 30
Testing effectiveness (Phase 2)Study completedNCT02401945
What this trial is testing

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 16
Not applicableStudy completedNCT03758963
What this trial is testing

Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy

Who this might be right for
Central Serous Chorioretinopathy
CynosureLutronic 63
Not applicableLooking for participantsNCT03848663
What this trial is testing

Visual Remapping to Aid Reading With Field Loss

Who this might be right for
Age-related Macular Degeneration
University of Minnesota 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121
What this trial is testing

Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
AiViva BioPharma, Inc. 35
Not applicableStudy completedNCT02941263
What this trial is testing

Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 20
Testing effectiveness (Phase 2)UnknownNCT03710863
What this trial is testing

Safety and Tolerability of Oral CM082 in Patients With wAMD

Who this might be right for
Age-Related Macular Degeneration
AnewPharma 64
Large-scale testing (Phase 3)Study completedNCT02818998
What this trial is testing

Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)

Who this might be right for
Macular Edema
Bayer 463
Not applicableStudy completedNCT01316198
What this trial is testing

Effects of Xanthophylls on Optical Density

Who this might be right for
Age-Related Macular Degeneration
University of Jena 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation